Kingmed Diagnostics shareholders approve corporate governance changes, scrap supervisory board

Guangzhou Kingmed Diagnostics Group Co., Ltd. held its second extraordinary general meeting of shareholders on September 9, 2025, at its headquarters in Guangzhou. Chaired by Mr. Liang Yaoming, the meeting saw 611 shareholders and their proxies present, representing 47.7270% of the company's total voting shares. All resolutions presented during the meeting were approved.

A key resolution passed was the cancellation of the company's Supervisory Board and the corresponding amendment of the Company Articles of Association and related rules. This resolution received significant support, with 212,380,585 votes in favor (96.0565%) from A-share holders. This was a special resolution requiring approval from over two-thirds of the attending shareholders, which it successfully obtained.

Shareholders also approved revisions to several internal management policies. These included amendments to the Related Party Transaction Management System, the External Investment Management System, and the External Guarantee Management System, all of which were passed. Beijing Zhonglun Law Firm confirmed the meeting proceedings and resolutions as legal and valid.